- Home
- VNDA
as of 02-26-2026 3:53pm EST
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 474.0M | IPO Year: | 2005 |
| Target Price: | $14.13 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.74 | EPS Growth: | -1033.33 |
| 52 Week Low/High: | $3.81 - $9.60 | Next Earning Date: | 05-13-2026 |
| Revenue: | $216,105,000 | Revenue Growth: | 8.72% |
| Revenue Growth (this year): | 26.2% | Revenue Growth (next year): | 31.02% |
| P/E Ratio: | -2.21 | Index: | N/A |
| Free Cash Flow: | -110440000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of Vanda Pharmaceuticals Inc. (VNDA)
Director
Avg Cost/Share
$8.03
Shares
30,000
Total Value
$240,900.00
Owned After
93,469
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Honore Tage | VNDA | Director | Feb 23, 2026 | Sell | $8.03 | 30,000 | $240,900.00 | 93,469 |
Compare VNDA vs Leading Stocks
See how VNDA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "VNDA Vanda Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.